SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CRINGE is a Solana meme token centered around all images, videos, and actions which are cringe!  Warning: Cringe Alert! Remember, folks! Just like we don't judge people based on race, ethnicity, or color, we shouldn't judge them for being cringe. After all, cringe isn't ugly - it's just... special. 😉  Embrace your inner cringe, because in a world full of copycats, being cringey is the new cool!  Meme coins are driven by community, and our community is CRINGE as heck!

CRINGE

CRINGE is generating intense community debate as participants navigate extreme price volatility and widespread concerns over potential pump-and-dump activity within the low market cap crypto sector. Investors are actively weighing the allure of rapid gains against the inherent risks of memecoin speculation, leading to polarized discussions regarding the long-term viability of the asset.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors digest recent earnings results, with the community actively debating the company's ability to drive significant year-over-year revenue growth through its QNX division and the ramp-up of new automotive software partnerships. While some market participants remain cautious regarding historical performance and guidance, others are increasingly focused on the potential for long-term expansion in the software-defined vehicle market.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive clinical data update and a significant analyst price target increase, fueling intense community discussion regarding its potential as a best-in-class treatment. Investors are actively monitoring institutional accumulation patterns and ongoing M&A speculation, with many focused on upcoming trial readouts that serve as key catalysts for potential long-term value.

Pendle is a protocol that enables the tokenization and trading of future yield. With the creation of a novel AMM that supports assets with time decay, Pendle gives users more control over future yield by providing optionality and opportunities for its utilization.

Pendle

Pendle is seeing significant momentum driven by massive whale accumulation and strategic endorsements from influential figures like Arthur Hayes, which have sparked community excitement over its role in the evolving DeFi yield-trading infrastructure. Investors are closely watching the project's institutional potential and RWA integration, with many debating whether the current price action signals a breakout or a consolidation phase within a broader bullish narrative.

The White Whale

White Whale is driving intense discussion following a major token burn and the locking of a significant portion of its supply until 2063, actions that supporters interpret as signs of strong long-term commitment. The community is actively debating the project's legitimacy and market dynamics, with many users highlighting these measures as a catalyst for potential price stability and a defense against market manipulation.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is currently experiencing high volatility driven by speculative retail interest, social media buzz surrounding potential short squeezes, and rumors of partnership developments. Community members are actively debating the token's long-term utility in decentralized infrastructure versus its history of rapid price pumps and sharp corrections.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is currently a focal point for investors as it navigates significant volatility and intense community debate over Bitcoin's long-term utility versus its speculative nature. Traders remain sharply divided, with ongoing discussions centered on the ETF's correlation with broader market sell-offs, the impact of institutional sentiment, and concerns regarding how the asset class will hold up amid macroeconomic pressures and geopolitical uncertainty.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing intense volatility and polarizing sentiment as the community debates whether the token is at a generational bottom or a dying project destined for further decline. Traders are hyper-focused on broader market liquidity, regulatory clarity, and Cardano's ability to maintain its ecosystem relevance amidst persistent downward pressure.

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Incyte Corp.

Incyte is currently trending as investors focus on a critical transition period, balancing strong legacy revenue from Jakafi against the pressure to demonstrate pipeline success through upcoming trial readouts and clinical milestones. The community is actively debating the company's valuation as a potential acquisition target, weighing its cash position and strategic partnerships against the looming patent cliffs.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing heightened investor interest and speculative trading as the market reacts to shifting regulatory sentiment at the FDA, which is currently re-evaluating its stance on trial design standards for oncology and rare disease assets. The community is actively debating whether recent FDA approvals for other biotech firms signal a potential reversal in the regulatory hurdles that previously led to a complete response letter (CRL) for the companys lead candidate, with traders heavily focused on upcoming PDUFA dates and the potential for a strategic or regulatory breakthrough.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canoe Financial LP Buys 194,555 Shares of CVS Health Corporation $CVS

Canoe Financial LP lifted its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 11.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities...

Wedge Capital Management L L P NC Has $27.60 Million Stock Holdings in CVS Health Corporation $CVS

Wedge Capital Management L L P NC reduced its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 347,804 shares of the pharmacy operator's stock af...

Wincap Financial LLC Lowers Stock Holdings in CVS Health Corporation $CVS

Wincap Financial LLC cut its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 86.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,672 shares of the pharmacy operator's stock after s...

Fort Washington Investment Advisors Inc. OH Boosts Holdings in CVS Health Corporation $CVS

Fort Washington Investment Advisors Inc. OH grew its position in CVS Health Corporation (NYSE:CVS - Free Report) by 2.9% during the 4th quarter, according to its most recent Form 13F filing with the...

Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS

Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its burn relief hydrogel in CVS and Walmart stores.read more...

Elon Musk's X Loses Advertiser Boycott Lawsuit As 'Teflon Elon' Legal Streak Unravels

Judge Boyle throws out Elon Musk's antitrust lawsuit against WFA, Nestle, Shell, Mars, CVS, and Colgate-Palmolive. X Corp failed to prove harm.read more...

Peak Financial Advisors LLC Acquires 19,298 Shares of CVS Health Corporation $CVS

Peak Financial Advisors LLC raised its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 105.9% during the fourth quarter, according to the company in its most recent 13F filing with the...

Dr. Oz warns foreign nationals may be tied to US hospice fraud, points to LA as hotspot

Networks of foreign nationals may be linked to U.S. hospice fraud, Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz warned Wednesday in a FOX Business special, pointing to one major city as a key area of concern."You have to ask yourself exactly how many people are actually...

Is BrightSpring BTSG Stock Expensive at 24.5x Forward P/E?

BTSG trades at 24.5x forward earnings after strong 2025 results, but 2026 hinges on margin gains offsetting policy-driven revenue headwinds.

BTSG Growth Drivers in 2026 Across Specialty and Providers

BTSG leans on specialty and provider growth in 2026, with margin expansion expected to outpace revenue despite near-term pharmacy headwinds.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

CVS
CVS Health Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CVS News

CVSCVS Health Corp